{"id":"W4214623152","doi":"10.3899/jrheum.210707","title":"Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials","year":2022,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada); Université Laval","funders":"Pfizer Canada; Pfizer; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Medicine; Tofacitinib; Adalimumab; Rheumatoid arthritis; Internal medicine; Rheumatology; Post-hoc analysis; Methotrexate; Placebo; Post hoc; Randomized controlled trial; Physical therapy; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06871277,0.003954449,0.007797175,0.001547981,0.0005056096,0.003355323,0.001340561,0.001540365,0.005016426],"category_scores_gemma":[0.06156877,0.0008836077,0.02095038,0.001939318,0.0009749514,0.001975756,0.001564546,0.002833734,0.0006115658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001604701,"about_ca_system_score_gemma":0.003022271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008151287,"about_ca_topic_score_gemma":0.001549392,"domain_scores_codex":[0.9275138,0.05587296,0.005827699,0.004434696,0.004404658,0.001946155],"domain_scores_gemma":[0.9297625,0.04860514,0.01136685,0.004739848,0.004182774,0.001343017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5970687,0.001138832,0.0224002,0.00682676,0.3304364,0.0001978741,0.0001427924,0.003633047,0.004559943,0.0002717983,0.004249989,0.02907366],"study_design_scores_gemma":[0.2175406,0.09290224,0.1594933,0.001539574,0.4901949,0.0004379356,0.0002834998,0.009807902,0.00999195,0.001376342,0.01614879,0.0002829919],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8239062,0.08668806,0.021862,0.002503938,0.003100274,0.02379138,0.02715193,0.000851633,0.01014461],"genre_scores_gemma":[0.9620833,0.004496735,0.007481575,0.001635142,0.0007769343,0.01263991,0.008027689,0.000459052,0.002399601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06871277,"threshold_uncertainty_score":0.3633922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04904478492997656,"score_gpt":0.3987752662992073,"score_spread":0.3497304813692307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}